Immunomedics
IMMU
$87.86
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Revenue for Immunomedics (IMMU)
Revenue in 2020 (TTM): $21.23 M
According to Immunomedics's latest financial reports the company's current revenue (TTM) is $21.23 M. In 2017 the company made a revenue of $3.25 M an increase over the years 2016 revenue that were of $2.95 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immunomedics from 2001 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 (TTM) | $21.23 M | |
| 2017 | $3.25 M | 10% |
| 2016 | $2.95 M | -40.62% |
| 2015 | $4.98 M | 12.78% |
| 2014 | $4.41 M | -54.93% |
| 2013 | $9.79 M | 158.04% |
| 2012 | $3.79 M | -91.17% |
| 2011 | $43.01 M | 122.79% |
| 2010 | $19.3 M | -68.21% |
| 2009 | $60.72 M | 297.36% |
| 2008 | $15.28 M | 329.31% |
| 2007 | $3.55 M | -65.09% |
| 2006 | $10.19 M | 294.58% |
| 2005 | $2.58 M | -39.59% |
| 2004 | $4.27 M | -55.59% |
| 2003 | $9.63 M | -48.69% |
| 2002 | $18.76 M | 73.31% |
| 2001 | $10.82 M |